Please login to the form below

Not currently logged in
Email:
Password:

Parexel appoints chief scientific officer

Promotion for Sy Pretorius
Paraxel Sy Pretorius

Parexel has promoted Dr Sy Pretorius to the position of chief scientific officer.

Dr Pretorius currently serves as worldwide head of early phase development at the contract research organisation (CRO) and will continue in that role in addition to his new duties.

These responsibilities include enhancing and leading the innovation of clinical research methodologies and helping Parexel to meet client demands. Key priorities include clinical trial modelling and simulations and adaptive trial designs.

Dr Pretorius knows the needs of Parexel well have spent nearly 18 years at the company. During this time he has served in a variety of positions, including corporate VP, clinical pharmacology in North America.

Parexel's president and chief operating officer Mark Goldberg said: “Pretorius has enjoyed a long and distinguished career at the Company, and applying his expertise more broadly will benefit customers and Parexel alike."

30th May 2014

From: Research

Share

Tags

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Envision Pharma Group

We are a global leader in the medical affairs space. Our purpose-built software and scientific solutions make us a unique...

Latest intelligence

The communication challenge of helping he next generation to be healthier
As the pressure on the health service increases the health of the next generation is vital for everyone. How do we show positive attitudes and change behaviour while future proofing...
Are we losing sight of what the democratisation of healthcare really looks like?
We have a core responsibility as healthcare communicators to consistently drive for better inclusion, engagement and compliance. What does the ‘democratisation of healthcare’ really look like?...
William Kilgallon
How the Royal Society’s EiR programme can help to drive UK innovation
...